Literature DB >> 18566990

Geographic variation of gallbladder cancer mortality and risk factors in Chile: a population-based ecologic study.

Marcelo E Andia1, Ann W Hsing, Gabriella Andreotti, Catterina Ferreccio.   

Abstract

Chile's gallbladder cancer rates are among the highest in the world, being the leading cause of cancer deaths among Chilean women. To provide insights into the etiology of gallbladder cancer, we conducted an ecologic study examining the geographical variation of gallbladder cancer and several putative risk factors. The relative risk of dying from gallbladder cancer between 1985 and 2003 was estimated for each of the 333 Chilean counties, using a hierarchical Poisson regression model, adjusting for age, sex and geographical location. The risk of gallbladder cancer mortality was analyzed in relation to region, poverty, Amerindian (Mapuche) population, typhoid fever and access to cholecystectomy, using logistic regression analysis. There were 27,183 gallbladder cancer deaths, with age and sex-adjusted county mortality rates ranging from 8.2 to 12.4 per 100,000 inhabitants. Rates were highest in inland and southern regions. Compared to the northern-coast, the northern-inland region had a 10-fold risk (95% of confidence interval (95% CI): 2.4-42.2) and the southern-inland region had a 26-fold risk (95% CI: 6.0-114.2). Independent of region, other risk factors for gallbladder cancer included a high Mapuche population (Odds ratio (OR):3.9, 95% CI 1.8-8.7), high typhoid fever incidence (OR:2.9, 95% CI 1.2-6.9), high poverty (OR:5.1, 95% CI 1.6-15.9), low access to cholecystectomy (OR:3.9, 95% CI 1.5-10.1), low access to hospital care (OR:14.2, 95% CI 4.2-48.7) and high urbanization (OR:8.0, 95% CI 3.4-18.7). Our results suggest that gallbladder cancer in Chile may be related to both genetic factors and poor living conditions. Future analytic studies are needed to further clarify the role of these factors in gallbladder cancer etiology. Copyright 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 18566990      PMCID: PMC2864002          DOI: 10.1002/ijc.23662

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  33 in total

Review 1.  Gallbladder cancer worldwide: geographical distribution and risk factors.

Authors:  Giorgia Randi; Silvia Franceschi; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2006-04-01       Impact factor: 7.396

2.  Biliary tract cancer and stones in relation to chronic liver conditions: A population-based study in Shanghai, China.

Authors:  Ann W Hsing; Yu-Tang Gao; Katherine A McGlynn; Shelley Niwa; Mingdong Zhang; Tian-Quan Han; Bing-Sheng Wang; Jinbo Chen; Lori C Sakoda; Ming-Chang Shen; Bai-He Zhang; Jie Deng; Asif Rashid
Journal:  Int J Cancer       Date:  2007-05-01       Impact factor: 7.396

3.  Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population.

Authors:  Iván Serra; Masaharu Yamamoto; Alfonso Calvo; Gabriel Cavada; Sergio Báez; Kazuo Endoh; Hidenobu Watanabe; Kazuo Tajima
Journal:  Int J Cancer       Date:  2002-12-01       Impact factor: 7.396

Review 4.  Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century?

Authors:  Eldon A Shaffer
Journal:  Curr Gastroenterol Rep       Date:  2005-05

5.  K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China.

Authors:  Asif Rashid; Takashi Ueki; Yu-Tang Gao; Patrick Scott Houlihan; Charita Wallace; Bing-Sheng Wang; Ming-Chang Shen; Jie Deng; Ann W Hsing
Journal:  Clin Cancer Res       Date:  2002-10       Impact factor: 12.531

6.  [Gallbladder cancer mortality in Chile and its relation to cholecystectomy rates. An analysis of the last decade].

Authors:  J Chianale; G Valdivia; G del Pino; F Nervi
Journal:  Rev Med Chil       Date:  1990-11       Impact factor: 0.553

7.  CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: a population-based study in Shanghai, China.

Authors:  Lifang Hou; Jianfeng Xu; Yu-Tang Gao; Asif Rashid; Síqun Lilly Zheng; Lori C Sakoda; Ming-Chang Shen; Bing-Sheng Wang; Jie Deng; Tian-Quan Han; Bai-He Zhang; Deborah A Meyers; Joseph F Fraumeni; Ann W Hsing
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

8.  Family history of gallstones and the risk of biliary tract cancer and gallstones: a population-based study in Shanghai, China.

Authors:  Ann W Hsing; Yan Bai; Gabriella Andreotti; Asif Rashid; Jie Deng; Jinbo Chen; Alisa M Goldstein; Tian-Quan Han; Ming-Chang Shen; Joseph F Fraumeni; Yu-Tang Gao
Journal:  Int J Cancer       Date:  2007-08-15       Impact factor: 7.396

9.  Risk factors for gallbladder cancer. An international collaborative case-control study.

Authors:  B L Strom; R D Soloway; J L Rios-Dalenz; H A Rodriguez-Martinez; S L West; J L Kinman; M Polansky; J A Berlin
Journal:  Cancer       Date:  1995-11-15       Impact factor: 6.860

Review 10.  Overview of epidemiology of bile duct and gallbladder cancer focusing on the JACC Study.

Authors:  Tsuyoshi Matsuba; Dongmei Qiu; Michiko Kurosawa; Yingsong Lin; Yutaka Inaba; Shogo Kikuchi; Kiyoko Yagyu; Yutaka Motohashi; Akiko Tamakoshi
Journal:  J Epidemiol       Date:  2005-06       Impact factor: 3.211

View more
  28 in total

1.  Gallbladder cancer: the basics.

Authors:  Eldon A Shaffer
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-10

Review 2.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 3.  Subversion of host genome integrity by bacterial pathogens.

Authors:  Cindrilla Chumduri; Rajendra Kumar Gurumurthy; Rike Zietlow; Thomas F Meyer
Journal:  Nat Rev Mol Cell Biol       Date:  2016-08-18       Impact factor: 94.444

4.  Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer.

Authors:  Xin Zheng; Lei Gao; Bo-Tao Wang; Ping Shen; Xiang-Fei Yuan; Lan-Qiu Zhang; Lei Yang; Da-Peng Zhang; Qi Zhang; Xi-Mo Wang
Journal:  Histol Histopathol       Date:  2019-11-20       Impact factor: 2.303

5.  Overexpression of the HER2/neu Gene: A New Therapeutic Possibility for Patients With Advanced Gallbladder Cancer.

Authors:  Iván Roa; Gonzalo de Toro; Kurt Schalper; Xabier de Aretxabala; Chaitanya Churi; Milind Javle
Journal:  Gastrointest Cancer Res       Date:  2014-03

Review 6.  Pathology of gallbladder carcinoma: current understanding and new perspectives.

Authors:  Munita Meenu Bal; Mukta Ramadwar; Kedar Deodhar; Shailesh Shrikhande
Journal:  Pathol Oncol Res       Date:  2015-01-25       Impact factor: 3.201

Review 7.  The potential role of comprehensive genomic profiling to guide targeted therapy for patients with biliary cancer.

Authors:  Hwajeong Lee; Jeffrey S Ross
Journal:  Therap Adv Gastroenterol       Date:  2017-03-28       Impact factor: 4.409

8.  Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America.

Authors:  Javier Torres; Pelayo Correa; Catterina Ferreccio; Gustavo Hernandez-Suarez; Rolando Herrero; Maria Cavazza-Porro; Ricardo Dominguez; Douglas Morgan
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

9.  Genetic variants involved in gallstone formation and capsaicin metabolism, and the risk of gallbladder cancer in Chilean women.

Authors:  Sergio Báez; Yasuo Tsuchiya; Alfonso Calvo; Martha Pruyas; Kazutoshi Nakamura; Chikako Kiyohara; Mari Oyama; Masaharu Yamamoto
Journal:  World J Gastroenterol       Date:  2010-01-21       Impact factor: 5.742

10.  Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression.

Authors:  Jean M Butte; Javiera Torres; Emanuela F Veras; Kenichi Matsuo; Mithat Gönen; Michael I D'Angelica; Enrique Waugh; Manuel Meneses; Yoshiyaki Inayama; Yuman Fong; Ronald P Dematteo; Hernan De La Fuente; Itaru Endo; David S Klimstra; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2012-12-01       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.